Coformer Screening Using Thermal Analysis Based on Binary Phase Diagrams

[1]  C. Chichester,et al.  Preparation, structural analysis, and properties of tenoxicam cocrystals. , 2012, International journal of pharmaceutics.

[2]  S. R. Bysouth,et al.  Cocrystallization via planetary milling: enhancing throughput of solid-state screening methods. , 2011, International journal of pharmaceutics.

[3]  R. Davey,et al.  Binary and Ternary Phase Diagrams as Routes to Salt Discovery: Ephedrine and Pimelic Acid , 2010 .

[4]  Katsuhiko Yamamoto,et al.  High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate. , 2010, International journal of pharmaceutics.

[5]  Henrique A. Matos,et al.  Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process , 2010 .

[6]  Christer B. Aakeröy,et al.  Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug. , 2009, Journal of the American Chemical Society.

[7]  William Jones,et al.  Improving Mechanical Properties of Crystalline Solids by Cocrystal Formation: New Compressible Forms of Paracetamol , 2009 .

[8]  Bing-Shiou Yang,et al.  A Practical Solid Form Screen Approach To Identify a Pharmaceutical Glutaric Acid Cocrystal for Development , 2009 .

[9]  T. Fukami,et al.  Characterization of multicomponent crystal formed between indomethacin and lidocaine , 2009, Drug development and industrial pharmacy.

[10]  Naír Rodríguez-Hornedo,et al.  Solubility Advantage of Pharmaceutical Cocrystals , 2009 .

[11]  S. Childs,et al.  The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome , 2009 .

[12]  David R. Weyna,et al.  Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution , 2009 .

[13]  Claus Cornett,et al.  Near-infrared spectroscopy for cocrystal screening. A comparative study with Raman spectroscopy. , 2008, Analytical chemistry.

[14]  K. Terada,et al.  Cocrystal Screening of Stanolone and Mestanolone Using Slurry Crystallization , 2008 .

[15]  Raj Suryanarayanan,et al.  A rapid thermal method for cocrystal screening , 2008 .

[16]  C. C. Seaton,et al.  Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients , 2008 .

[17]  Changquan Calvin Sun,et al.  Improving Mechanical Properties of Caffeine and Methyl Gallate Crystals by Cocrystallization , 2008 .

[18]  S. Velaga,et al.  Indomethacin–Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization , 2008, Pharmaceutical Research.

[19]  G. P. Stahly.  Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals , 2007 .

[20]  T. Friščić,et al.  Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding. , 2007, Molecular pharmaceutics.

[21]  Christer B Aakeröy,et al.  Cocrystal or salt: does it really matter? , 2007, Molecular pharmaceutics.

[22]  Geoff G. Z. Zhang,et al.  Efficient co-crystal screening using solution-mediated phase transformation. , 2007, Journal of pharmaceutical sciences.

[23]  William Jones,et al.  Pharmaceutical Cocrystals: An Emerging Approach to Physical Property Enhancement , 2006 .

[24]  W. Motherwell,et al.  Physical stability enhancement of theophylline via cocrystallization. , 2006, International journal of pharmaceutics.

[25]  Aeri Park,et al.  Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.

[26]  Chick C. Wilson,et al.  Electron and nuclear positions in the short hydrogen bond in urotropine-N-oxide.formic acid. , 2005, Journal of Physical Chemistry A.

[27]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[28]  Orn Almarsson,et al.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.

[29]  J. Keith Guillory,et al.  Handbook of Pharmaceutical Salts: Properties, Selection, and Use Edited by P. Heinrich Stahl and Camile G. Wermuth. VHCA, Verlag Helvetica Chimica Acta, Zürich, Switzerland, and Wiley-VCH, Weinheim, Germany. 2002. vix + 374 pp. 17.5 × 24.5 cm. ISBN 3-906390-26-8. $130.00 , 2003 .

[30]  R. G. Cantera,et al.  Solid phases of tenoxicam. , 2002, Journal of pharmaceutical sciences.

[31]  A. Kalgutkar,et al.  On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin , 2013 .

[32]  K. Terada,et al.  Detection of Cocrystal Formation Based on Binary Phase Diagrams Using Thermal Analysis , 2012, Pharmaceutical Research.

[33]  Hiroshi Tomiyama,et al.  Antidiabetic effects of SGLT2-selective inhibitor ipragliflozin in streptozotocin-nicotinamide-induced mildly diabetic mice. , 2012, Journal of pharmacological sciences.

[34]  J. Wouters,et al.  Pharmaceutical Salts and Co-crystals , 2011 .